Clinical presentation, diagnosis and treatment of intrahepatic cholestasis of pregnancy
https://doi.org/10.22416/1382-4376-2017-27-4-96-101
Abstract
Aim of the lecture. To present the modern concept of etiology and pathogenesis of the intrahepatic cholestasis of pregnancy (ICP) and the modern diagnostic and treatment approaches to gastroenterologists. Summary. The etiology and pathogenesis of ICP are related to disorders of bile acid metabolism caused by hormonal factors (elevation of estrogen and progesterone levels) and genetic predisposition. The leading clinical signs of ICP include pruritus and jaundice that develop most commonly in the third trimester of pregnancy, and characteristic changes of laboratory scores: increase in bile acid level (over 10 mcmol/l) and moderate elevation of transaminase activity. Severity of ICP and complication risk for mother and fetus correlate to the degree of bile acids elevation. The most effective agent for ICP treatment is ursodeoxycholic acid (UDCA). Conclusion. Timely diagnostics of ICP and early UDCA administration, fetus condition control and early delivery at severe ICP cases allows to prevent development of serious complications and to achieve favorable pregnancy outcome.
About the Authors
Yu. B. Uspenskaya
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
A. A. Sheptulin
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
References
1. Keitel V., DrÖge C., Stepanow S. et al. Intrahepatic cholestasis of pregnancy (ICP): case report and review of the literature. Z. Gastroenterol 2016; 54: 1327-33.
2. Герок В., Блюм Х.Е. Заболевания печени и жёлчевыделительной системы (пер. с нем.). М. «МЕДпрессинформ» 2009
3. Maier K.P. Hepatitis - Hepatitisfolgen. 6.Auflage. Bern, Hans Huber Verlag 2010.
4. Бурков С.Г., Положенкова Л.А. Болезни органов пищеварения и беременность // Руководство по гастроэнтерологии (под ред. Ф.И. Комарова и А.Л. Гребенева). М., 1996, т.3.: 677-701.
5. Блюгер А.Ф., Новицкий И.Н. Практическая гепатология. Рига, «Звайгзне», 1984.
6. Успенская Ю.Б., Гончаренко Н.В. Современное состояние проблемы холестаза у беременных. Проблемы женского здоровья 2017 (3): 70-7.
7. Abu-Hayyeh S., Ovadia C., Lieu T.M. et al. Prognostic and Mechanistic Potential of Progesterone Sulfates in Intrahepatic Cholestasis of Pregnancy and Pruritus Gravidarum. Hepatology 2016; 63 (4): 11287-298
8. Floreany A., Carderi L., Paternoster D. et al. Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations. Aliment. Pharmacol. Ther 2006; 23 (11): 1649-53.
9. Jacquemin E., De Vree J.M., Cresteil D. et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001; 120 (6): 1448-58.
10. Sookofan S., Castano G., Burgueno A. et al. Association of the multidrug-resistsnce-associated protein gene (ABCC2) variants with intrahepatiс cholestasis of pregnancy. J Hepatol 2008; 48:125.
11. Pařizek A., Hill M., Dušková M. A comprehensive evaluation of steroid metabolism in women with intrahepatic cholestasis of pregnancy. PLoS ONE2016; 11 (8): e0159203. Doi: 10.1371/journal pone.0159203.
12. Kuntz E., Kuntz H.D. Hepatology: principles and practice. Springer Verlag. Berlin-Heidelberg-NewYork 2002.
13. Riely C.A., Davila R. Pregnancy-related hepatic and gastrointestinal disorders. In: Sleisenger & Fordtran’s gastrointestinal and liver disease: pathophy siology, diagnosis, management [ed. by M. Feldman, L.S. Friedman, Sleisenger M.H.]. -7th ed. 2002.
14. Ивашкин В.Т., Маевская М.В., Жаркова М.С. и др. Алгоритмы диагностики и лечения в гепатологии. М., «МЕДпресс-информ», 2-е изд. 2017.
15. Pařizek A., Šimják P., Černý A. Efficacy and safety or ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Ann Hepatol 2016; 15 (5):757-61.
16. Feng D., He W. Asymptomatic elevated total serum bile aсids represent ting an unusual form of intrahepatic cholestasis of pregnancy. Int J Gynecol Obstet 2016; 134 (3):343-4.
17. Feng D., Yang X.J. A clinical dilemma: pregnancy with asymptomatic elevated total serum bile acid levels. J Obstet Gynecol 2014.; 34 (5):444-5.
18. Pascual M., Serrano M.A., El-Mir M.Y., et al. Relationship between asymptomatic hypercholanaemia of pregnancy and progesterone metabolism. Clin.Sci (Lond) 2002;102 (5):587-93.
19. Лейшнер У. Аутоиммунные заболевания печени и перекрестный синдром. М., Анахарсис, 2005.
20. Lee R.H., Kwok K.M., Ingles S., et al. Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. Am.J. Perinatol 2008; 25:341-5.
21. Glantz A., Marshall H.U., Mattsson L.A. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complications rates. Hepatology 2004; 40(2):467-74.
22. Estu M.C., Frailuna M.A., Otero C. et al. Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid. PLoS ONE2017; 12(4): e0176504.
23. Bacq Y., Sentilhes L., Reyes H.B. et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy. Gastroenterology 2012; 143 (6): 1492-501.
24. Serrano M.A., Macias R.I., Vallejo M. et al. Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placents-maternal liver tandem excretory pathway. J Pharmacol Exp Ther 2003; 305: 515-24.
25. Kong X., Kong X., Zhang F. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study). Medicine (Baltimore) 2016; 95 (40): e4949.
26. Bacq Y., Le Besco M., Lecuyer A.-I. Ursodeoxycholic acid therapy in intrahepatic cholestasis of pregnancy: Results in real-world conditions and factors predictive of response to treatment. Dig Liver Dis 2017; 49:63-9.
27. Zhang Y., Lu L., Victor D.M., et al. Ursodeoxycholic acid and S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy: a meta-analysis. Hepat Mon 2016; 16 (8):e38558.
Review
For citations:
Uspenskaya Yu.B., Sheptulin A.A. Clinical presentation, diagnosis and treatment of intrahepatic cholestasis of pregnancy. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(4):96-101. (In Russ.) https://doi.org/10.22416/1382-4376-2017-27-4-96-101
Views:
2531
Email this article 
